Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01174121
Recruitment Status : Suspended
First Posted : August 3, 2010
Last Update Posted : January 28, 2021
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : December 29, 2023
Estimated Study Completion Date : December 27, 2024
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):